These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 11238675)

  • 1. Identification of a matrix-degrading phenotype in human tuberculosis in vitro and in vivo.
    Price NM; Farrar J; Tran TT; Nguyen TH; Tran TH; Friedland JS
    J Immunol; 2001 Mar; 166(6):4223-30. PubMed ID: 11238675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical analysis of MMP-9, MMP-2 and TIMP-1, TIMP-2 expression in the central nervous system following infection with viral and bacterial meningitis.
    Sulik A; Chyczewski L
    Folia Histochem Cytobiol; 2008; 46(4):437-42. PubMed ID: 19141395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential regulation of MMP-1/9 and TIMP-1 secretion in human monocytic cells in response to Mycobacterium tuberculosis.
    Friedland JS; Shaw TC; Price NM; Dayer JM
    Matrix Biol; 2002 Jan; 21(1):103-10. PubMed ID: 11827797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unopposed matrix metalloproteinase-9 expression in human tuberculous granuloma and the role of TNF-alpha-dependent monocyte networks.
    Price NM; Gilman RH; Uddin J; Recavarren S; Friedland JS
    J Immunol; 2003 Nov; 171(10):5579-86. PubMed ID: 14607966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased activity of matrix metalloproteinases in the cerebrospinal fluid of patients with HIV-associated neurological diseases.
    Liuzzi GM; Mastroianni CM; Santacroce MP; Fanelli M; D'Agostino C; Vullo V; Riccio P
    J Neurovirol; 2000 Apr; 6(2):156-63. PubMed ID: 10822329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Marked increase of matrix metalloproteinase 9 in cerebrospinal fluid of patients with fungal or tuberculous meningoencephalitis.
    Matsuura E; Umehara F; Hashiguchi T; Fujimoto N; Okada Y; Osame M
    J Neurol Sci; 2000 Feb; 173(1):45-52. PubMed ID: 10675579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Title: role of matrix metalloproteinase -9 in progression of tuberculous meningitis: a pilot study in patients at different stages of the disease.
    Majeed S; Singh P; Sharma N; Sharma S
    BMC Infect Dis; 2016 Nov; 16(1):722. PubMed ID: 27899068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in viral meningitis: upregulation of MMP-9 and TIMP-1 in cerebrospinal fluid.
    Kolb SA; Lahrtz F; Paul R; Leppert D; Nadal D; Pfister HW; Fontana A
    J Neuroimmunol; 1998 Apr; 84(2):143-50. PubMed ID: 9628456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of purulent meningitis on the changes of matrix metalloproteinase-2 (MMP-2) and matrix metalloproteinase inhibitor-1 (TIMP-1) in cerebrospinal fluid of neonates.
    Cui W; Luo X; Zhang Y
    Pak J Pharm Sci; 2019 Sep; 32(5(Special)):2437-2441. PubMed ID: 31894031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum matrix metalloproteinase-2 levels indicate blood-CSF barrier damage in patients with infectious meningitis.
    Kanoh Y; Ohara T; Kanoh M; Akahoshi T
    Inflammation; 2008 Apr; 31(2):99-104. PubMed ID: 18185989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistent increase of matrix metalloproteinases in cerebrospinal fluid of tuberculous meningitis.
    Lee KY; Kim EH; Yang WS; Ryu H; Cho SN; Lee BI; Heo JH
    J Neurol Sci; 2004 May; 220(1-2):73-8. PubMed ID: 15140609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated Matrix Metalloproteinase Concentrations Offer Novel Insight Into Their Role in Pediatric Tuberculous Meningitis.
    Li YJ; Wilkinson KA; Wilkinson RJ; Figaji AA; Rohlwink UK
    J Pediatric Infect Dis Soc; 2020 Feb; 9(1):82-86. PubMed ID: 30753686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matrix metalloproteinase (MMP)-8 and MMP-9 in cerebrospinal fluid during bacterial meningitis: association with blood-brain barrier damage and neurological sequelae.
    Leppert D; Leib SL; Grygar C; Miller KM; Schaad UB; Holländer GA
    Clin Infect Dis; 2000 Jul; 31(1):80-4. PubMed ID: 10913401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Potential Role of Matrix Metalloproteinases 8 and 9 and Myeloperoxidase in Predicting Outcomes of Bacterial Meningitis of Childhood.
    Savonius O; Roine I; Alassiri S; Tervahartiala T; Helve O; Fernández J; Peltola H; Sorsa T; Pelkonen T
    Mediators Inflamm; 2019; 2019():7436932. PubMed ID: 31780869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebrospinal fluid matrix metalloproteinase 9 levels, blood-brain barrier permeability, and treatment outcome in tuberculous meningitis.
    Mailankody S; Dangeti GV; Soundravally R; Joseph NM; Mandal J; Dutta TK; Kadhiravan T
    PLoS One; 2017; 12(7):e0181262. PubMed ID: 28704492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated levels of MMP-9 and TIMP-1 in the cerebrospinal fluid of children with echovirus type 30 and mumps meningitis.
    Sulik A; Wojtkowska M; Oldak E
    Scand J Immunol; 2008 Sep; 68(3):323-7. PubMed ID: 18565120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of transforming growth factor β1 on the expression of matrix metalloproteinase 9, tissue inhibitor of metalloproteinase 1 and nuclear factor kappa B signalling pathway in the human amniotic cells WISH].
    Fan MS; Jiang ZY; Zou YF; Qu L; Zhou X; Sun LZ
    Zhonghua Fu Chan Ke Za Zhi; 2013 Jan; 48(1):29-33. PubMed ID: 23531248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic changes of matrix metalloproteinase-9 in patients with Klebsiella pneumoniae meningitis.
    Tsai HC; Liu SF; Wu KS; Liu YC; Shi MH; Chen ER; Yen CM; Lee SS; Huang YL; Chen YS
    Inflammation; 2008 Aug; 31(4):247-53. PubMed ID: 18553165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Matrix metalloproteinase-9 (MMP-9) in human cerebrospinal fluid (CSF): elevated levels are primarily related to CSF cell count.
    Yushchenko M; Weber F; Mäder M; Schöll U; Maliszewska M; Tumani H; Felgenhauer K; Beuche W
    J Neuroimmunol; 2000 Oct; 110(1-2):244-51. PubMed ID: 11024556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cilostazol inhibits matrix invasion and modulates the gene expressions of MMP-9 and TIMP-1 in PMA-differentiated THP-1 cells.
    Chuang SY; Yang SH; Chen TY; Pang JH
    Eur J Pharmacol; 2011 Nov; 670(2-3):419-26. PubMed ID: 21925496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.